What does Delineate do?

Delineate is an AI startup based in Boston, MA, founded in 2024 by Jawad Iqbal and Emily Nieves. The company has around 20 employees and is backed by Y Combinator, a $3.2 million seed round, and an active NIH grant. Delineate specializes in AI agents designed to accelerate clinical trial design and model-informed drug development within the pharmaceutical R&D market. The company develops custom large language models and computer vision tools that streamline the evidence aggregation process from various research sources. Their key offerings include autonomous agents for study clustering and ranking, AI extraction from complex data formats, and a web-based platform for modeling and analysis. These tools aim to enhance decision-making for drug pipelines, addressing the high failure rates of drug candidates by improving the efficiency of clinical trial design and data product creation. Delineate serves pharmaceutical companies, R&D teams, and biotech firms focused on drug development.